Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
Authors
Keywords
-
Journal
Diabetology & Metabolic Syndrome
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-13
DOI
10.1186/s13098-021-00695-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes
- (2021) Pierre Jordaan et al. TOXICOLOGICAL SCIENCES
- Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressure
- (2021) N. De Vita et al. Pulmonology
- Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study
- (2021) Matthieu Wargny et al. DIABETOLOGIA
- Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes
- (2021) Jingya Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity.
- (2021) Carolyn T. Bramante et al. JOURNAL OF MEDICAL VIROLOGY
- Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study
- (2021) Xueqi Cheng et al. LIFE SCIENCES
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19
- (2020) Javier A. Menendez Aging-US
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
- (2020) Pan Luo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
- (2020) Yuchen Chen et al. DIABETES CARE
- Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory
- (2020) Antonio Ceriello DIABETES RESEARCH AND CLINICAL PRACTICE
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Metformin and COVID‐19: A novel deal of an Old Drug
- (2020) Amr Ahmed EL‐Arabey et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
- (2020) Yongli Yan et al. BMJ Open Diabetes Research & Care
- Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes
- (2020) Gianluca Iacobellis et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
- (2020) Awadhesh Kumar Singh et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Letter to the Editor: Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
- (2020) Casey Means METABOLISM-CLINICAL AND EXPERIMENTAL
- Practical recommendations for the management of diabetes in patients with COVID-19
- (2020) Stefan R Bornstein et al. Lancet Diabetes & Endocrinology
- COVID-19 in people with diabetes: understanding the reasons for worse outcomes
- (2020) Matteo Apicella et al. Lancet Diabetes & Endocrinology
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Xu Cheng et al. Cell Metabolism
- Risk of Metformin in Patients With Type 2 Diabetes With COVID‐19: A Preliminary Retrospective Report
- (2020) Yongchao Gao et al. CTS-Clinical and Translational Science
- Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399–1407
- (2020) Bertrand Cariou et al. DIABETES CARE
- Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
- (2020) Niki Katsiki et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Metformin is associated with Decreased 30-day Mortality among Nursing Home Residents Infected with SARS-CoV2
- (2020) Michelle Lally et al. Journal of the American Medical Directors Association
- A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin
- (2020) Jamie N. Justice et al. GeroScience
- Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
- (2020) Luis M. Pérez-Belmonte et al. BMC Medicine
- Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study
- (2020) Nan Jiang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Impact of Diabetes in Patients Diagnosed With COVID-19
- (2020) Mohamed Abu-Farha et al. Frontiers in Immunology
- Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus
- (2020) Yu-Huang Liao et al. Journal of Clinical Medicine
- Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
- (2020) Jun Young Do et al. DIABETES & METABOLISM
- Update on off label use of metformin for obesity
- (2018) Amr Ahmed EL-Arabey Primary Care Diabetes
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started